Benjamin Edwards Inc. Has $2.08 Million Position in Tempus AI, Inc. (NASDAQ:TEM)

Benjamin Edwards Inc. boosted its stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 19.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,137 shares of the company's stock after acquiring an additional 7,149 shares during the quarter. Benjamin Edwards Inc.'s holdings in Tempus AI were worth $2,081,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in shares of Tempus AI by 6,247.5% in the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock valued at $289,204,000 after buying an additional 5,900,668 shares during the last quarter. ARK Investment Management LLC raised its holdings in shares of Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock valued at $361,867,000 after buying an additional 1,981,755 shares during the last quarter. Nikko Asset Management Americas Inc. raised its holdings in shares of Tempus AI by 31.5% in the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company's stock valued at $205,401,000 after buying an additional 1,021,460 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Tempus AI by 31.4% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock valued at $205,284,000 after buying an additional 1,016,384 shares during the last quarter. Finally, Mariner LLC bought a new position in shares of Tempus AI in the fourth quarter valued at about $31,187,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Price Performance

Tempus AI stock opened at $60.82 on Tuesday. The firm has a market capitalization of $10.53 billion, a P/E ratio of -51.11 and a beta of 4.98. Tempus AI, Inc. has a 1 year low of $31.36 and a 1 year high of $91.45. The business has a 50-day moving average of $62.41 and a 200-day moving average of $58.14. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 2.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.01. The company had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative return on equity of 157.53% and a negative net margin of 20.98%. The company's revenue for the quarter was up 89.5% compared to the same quarter last year. During the same period in the previous year, the company earned ($6.86) EPS. On average, equities analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Activity at Tempus AI

In other news, CFO James William Rogers sold 23,121 shares of the business's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $63.27, for a total transaction of $1,462,865.67. Following the completion of the transaction, the chief financial officer directly owned 146,001 shares in the company, valued at approximately $9,237,483.27. The trade was a 13.67% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Andrew Polovin sold 17,552 shares of the business's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $63.43, for a total value of $1,113,323.36. Following the transaction, the executive vice president owned 138,877 shares of the company's stock, valued at $8,808,968.11. The trade was a 11.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 758,772 shares of company stock worth $51,005,175. 27.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

TEM has been the subject of a number of research analyst reports. Bank of America lifted their price target on Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th. BTIG Research assumed coverage on Tempus AI in a report on Friday. They issued a "buy" rating and a $60.00 price target for the company. Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a research report on Friday. Needham & Company LLC reiterated a "buy" rating and issued a $70.00 price objective on shares of Tempus AI in a research report on Friday. Finally, Guggenheim lifted their price objective on Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research report on Monday, June 30th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $65.09.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.